Cprx stock forecast

US $139.00
List price US $136.000 (55% off)
777 sold
This one's trending. 55139 have already sold.
Breathe easy. Returns accepted.

To get a sense of who is truly in control of Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX ), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 81% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk). Smart Portfolio is supported by our partner TipRanks. By connecting my portfolio to TipRanks Smart Portfolio I agree to their Terms of Use . Bio-pharma indexes confirm sector tailwinds.